WO2001075095A1 - Procede de production de proteine de recombinaison - Google Patents

Procede de production de proteine de recombinaison Download PDF

Info

Publication number
WO2001075095A1
WO2001075095A1 PCT/JP2001/002712 JP0102712W WO0175095A1 WO 2001075095 A1 WO2001075095 A1 WO 2001075095A1 JP 0102712 W JP0102712 W JP 0102712W WO 0175095 A1 WO0175095 A1 WO 0175095A1
Authority
WO
WIPO (PCT)
Prior art keywords
recombinant protein
protein
salt
solution containing
expressed
Prior art date
Application number
PCT/JP2001/002712
Other languages
English (en)
French (fr)
Inventor
Takao Yamada
Isamu Tsuji
Hideki Matsui
Original Assignee
Takeda Chemical Industries, Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries, Ltd. filed Critical Takeda Chemical Industries, Ltd.
Priority to AU2001244647A priority Critical patent/AU2001244647A1/en
Priority to CA002404567A priority patent/CA2404567A1/en
Priority to EP01917667A priority patent/EP1273655A4/en
Publication of WO2001075095A1 publication Critical patent/WO2001075095A1/ja

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70575—NGF/TNF-superfamily, e.g. CD70, CD95L, CD153, CD154
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
PCT/JP2001/002712 2000-03-30 2001-03-30 Procede de production de proteine de recombinaison WO2001075095A1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AU2001244647A AU2001244647A1 (en) 2000-03-30 2001-03-30 Process for producing recombinant protein
CA002404567A CA2404567A1 (en) 2000-03-30 2001-03-30 Process for producing recombinant protein
EP01917667A EP1273655A4 (en) 2000-03-30 2001-03-30 METHOD FOR PRODUCING A RECOMBINANT PROTEIN

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000097891 2000-03-30
JP2000-097891 2000-03-30

Publications (1)

Publication Number Publication Date
WO2001075095A1 true WO2001075095A1 (fr) 2001-10-11

Family

ID=18612453

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2001/002712 WO2001075095A1 (fr) 2000-03-30 2001-03-30 Procede de production de proteine de recombinaison

Country Status (5)

Country Link
US (1) US20030120042A1 (ja)
EP (1) EP1273655A4 (ja)
AU (1) AU2001244647A1 (ja)
CA (1) CA2404567A1 (ja)
WO (1) WO2001075095A1 (ja)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1179347A1 (en) * 1999-05-21 2002-02-13 Takeda Chemical Industries, Ltd. Liver function controlling agents
WO2004056872A1 (ja) * 2002-12-20 2004-07-08 Mitsubishi Pharma Corporation タンパク質のチオール基を保護する方法

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080032343A1 (en) * 2005-12-22 2008-02-07 Genentech, Inc. Recombinant Production of Heparin Binding Proteins
RU2439076C2 (ru) 2006-07-14 2012-01-10 Дженентек, Инк. Способ выделения повторно свернутого рекомбинантного белка из культуры прокариотических клеток (варианты)
EP2086575A2 (en) * 2006-10-25 2009-08-12 La Jolla Institute For Allergy And Immunology Light-mediated anti-cell proliferative compositions and methods
WO2008102469A1 (ja) * 2007-02-23 2008-08-28 Kwansei Gakuin Educational Foundation 蛋白質結晶化剤および蛋白質結晶化剤を用いた蛋白質結晶化方法
EP2019117A1 (en) * 2007-07-27 2009-01-28 BIOPHARM GESELLSCHAFT ZUR BIOTECHNOLOGISCHEN ENTWICKLUNG VON PHARMAKA mbH Optimized purification process of recombinant growth factor protein

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996040736A1 (en) * 1995-06-07 1996-12-19 Celtrix Pharmaceuticals, Inc. Method of producing igf-i and igfbp-3 with correct folding and disulfide bonding
WO1998003648A1 (en) * 1996-07-19 1998-01-29 Takeda Chemical Industries, Ltd. Fas ligand-like protein, its production and use
WO1998029559A1 (fr) * 1996-12-25 1998-07-09 Hoechst Marion Roussel Ltd. Procede de preparation de dimeres purifies a partir de facteur derive de l'os
JPH10191989A (ja) * 1996-11-12 1998-07-28 Takeda Chem Ind Ltd ベータセルリン類の製造方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW440566B (en) * 1994-07-25 2001-06-16 Novartis Ag Novel process for the production of biologically active dimeric protein
US6001329A (en) * 1996-05-06 1999-12-14 Uab Research Foundation Radiolabeled fusion toxins for cancer therapy
AU2001240149A1 (en) * 2000-03-13 2001-09-24 Amgen Inc Fibroblast growth factor-like molecules and uses thereof

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996040736A1 (en) * 1995-06-07 1996-12-19 Celtrix Pharmaceuticals, Inc. Method of producing igf-i and igfbp-3 with correct folding and disulfide bonding
WO1998003648A1 (en) * 1996-07-19 1998-01-29 Takeda Chemical Industries, Ltd. Fas ligand-like protein, its production and use
JPH10191989A (ja) * 1996-11-12 1998-07-28 Takeda Chem Ind Ltd ベータセルリン類の製造方法
WO1998029559A1 (fr) * 1996-12-25 1998-07-09 Hoechst Marion Roussel Ltd. Procede de preparation de dimeres purifies a partir de facteur derive de l'os

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
JEREMY A. HARROP ET AL.: "Herpesvirus entry mediator ligand (HVEM-L), a novel ligand for HVEM/TR2, stimulates proliferation of T cells and inhibits HT29 cell growth", THE JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 273, no. 42, October 1998 (1998-10-01), pages 27548 - 27556, XP002947574 *
MAURI D.N. ET AL.: "LIGHT, a new member of the TNF superfamily and lymphotoxin alpha are ligands for herpesvirus entry mediator", IMMUNITY, vol. 8, no. 1, 1998, pages 21 - 30, XP002947575 *
YIFAN ZHAI ET AL.: "LIGHT, a novel ligand for lymphotoxin beta receptor and TR2/HVEM induces apoptosis and suppresses in vivo tumor formation via gene transfer", J. CLIN. INVEST., vol. 102, no. 6, 1998, pages 1142 - 1151, XP002947576 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1179347A1 (en) * 1999-05-21 2002-02-13 Takeda Chemical Industries, Ltd. Liver function controlling agents
EP1179347A4 (en) * 1999-05-21 2002-06-26 Takeda Chemical Industries Ltd HEPATIC FUNCTION REGULATORS
WO2004056872A1 (ja) * 2002-12-20 2004-07-08 Mitsubishi Pharma Corporation タンパク質のチオール基を保護する方法

Also Published As

Publication number Publication date
EP1273655A4 (en) 2004-08-04
EP1273655A1 (en) 2003-01-08
AU2001244647A1 (en) 2001-10-15
US20030120042A1 (en) 2003-06-26
CA2404567A1 (en) 2001-10-11

Similar Documents

Publication Publication Date Title
EP2330199A3 (en) Surfactant tolerant cellulase and method for modification thereof
CA2423887A1 (en) Recombinant terminal deoxynucleotidyl transferase with improved functionality
NZ515781A (en) Compositions and methods comprising morphine gluconate
CA2349168A1 (en) Hyaluronic acid gel, method of its production and medical material containing it
HK1050014A1 (en) Methods for refolding proteins containing free cysteine residues
DE60312333D1 (de) Einen lipophilen wirkstoff enthaltende feste pharmazeutische zusammensetzung sowie deren herstellung
CA2000604A1 (en) Process for the activation of genetechnologically produced, biologically-active proteins expressed in prokaryotes
JPH06503473A (ja) 融合ポリペプチド
WO2001075095A1 (fr) Procede de production de proteine de recombinaison
WO2003020200A8 (en) A novel pharmaceutical compound and methods of making and using same
WO2000037487A8 (de) INHIBITOREN DES INTEGRINS αvβ¿6?
FR2827174B1 (fr) Utilisation de peptides pour augmenter l'adhesion cellulaire
EP1329461A4 (en) PROCESS FOR PREVENTING POLYMERS OF HUMAN SERUM ALBUMIN
WO2000069901A3 (en) Proteins with insulin-like activity useful in the treatment of diabetes
AU4653301A (en) Anti-freeze proteins, their production and use
WO2003008449A8 (en) Ntb-a, a surface molecule involved in natural killer cells activity
BR0215585A (pt) Processo de produção de fator de desenvolvimento placentário
EP0315118A3 (en) Dna coding for endothelin and use thereof
WO2003059323A3 (de) Stabile salze von o-acetylsalicylsäure mit basischen aminosäuren ii
WO2003029457A1 (fr) Procede de production d'acide amine
WO2004046199A3 (fr) Procede d'obtention d'acide chondroitine sulfurique et ses utilisations
WO2002080940A3 (en) Pharmacologically active strong acid solutions
BR0009636A (pt) Preparação de procarboxipeptidase b pancreática, formas iso e muteìnas das mesmas e seu emprego
JP2001107078A5 (ja)
WO2001051489A3 (en) Methods for lowering uric acid levels

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2001917667

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 10240295

Country of ref document: US

Ref document number: 2404567

Country of ref document: CA

WWP Wipo information: published in national office

Ref document number: 2001917667

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Ref document number: 2001917667

Country of ref document: EP